Baseline characteristics: non-perigraft seroma patients versus perigraft seroma patients
| . | No PGS . | PGS (+) . | P-value . |
|---|---|---|---|
| . | Data (N = 70) . | Data (N = 12) . | . |
| Male, n (%) | 42 (60.0) | 7 (58.3) | >0.999 a |
| Female, n (%) | 28 (40.0) | 5 (41.7) | |
| Age, n (%) | 74.6 ± 8.9 | 71.4 ± 12.2 | 0.287 b |
| Body surface area (m2) | 1.6 ± 0.2 | 1.6 ± 0.2 | 0.721 b |
| Hyperlipidaemia, n (%) | 38 (55.1) | 7 (58.3) | >0.999 a |
| Anticoagulation (W/D), n (%) | 17 (24.3) | 4 (33.3) | 0.493 a |
| Warfarin, n (%) | 10 (14.3) | 4 (33.3) | 0.205 a |
| Aspirin, n (%) | 27 (37.5) | 4 (40) | >0.999 a |
| Steroid, n (%) | 3 (4.2) | 1 (10) | 0.412 a |
| Diuretics, n (%) | 26 (36.1) | 3 (30) | >0.999 a |
| Diabetes mellitus, n (%) | 14 (20.0) | 2 (16.7) | >0.999 a |
| Smoking, n (%) | 24 (34.3) | 6 (50.0) | 0.341 a |
| Hypertension, n (%) | 56 (80.0) | 12 (100.0) | 0.116 a |
| Peripheral vascular disease, n (%) | 13 (18.6) | 2 (16.7) | >0.999 a |
| Lung disease, n (%) | 6 (8.6) | 1 (8.3) | >0.999 a |
| Arrhythmia, n (%) | 4 (5.7) | 0 (0.0) | >0.999 a |
| Previous angina, MI, n (%) | 8 (11.4) | 1 (8.3) | >0.999 a |
| Cerebral vascular disease, n (%) | 14 (20.0) | 2 (16.7) | >0.999 a |
| Previous heart surgery, n (%) | 9 (12.9) | 1 (9.1) | >0.999 a |
| Preoperative albumin level, n (%) | 4.1 ± 0.3 | 4.1 ± 0.4 | 0.888 b |
| Haemodialysis, n (%) | 4 (5.7) | 1 (8.3) | 0.556 a |
| Serum creatinine (mg/dl) | 0.9 [0.6, 1.2] | 0.9 [0.8, 1.3] | 0.455 c |
| Ejection fraction (%) | 62.8 ± 7.1 | 67.4 ± 4.1 | 0.032 b |
| Aortic valve, n (%) | 0.716 a | ||
| Aortic stenosis (AS) | 4 (5.7) | 1 (8.3) | |
| Aortic regurgitation (AR) | 14 (20.0) | 3 (25.0) | |
| AS + AR/ASR | 8 (11.4) | 2 (16.7) | |
| Mitral valve, n (%) | 7 (10.0) | 3 (25.0) | 0.159 a |
| Degenerative aneurysm, n (%) | 42 (60.0) | 3 (25.0) | 0.031 a |
| Aortic dissection (type A/B), n (%) | 28 (40.0) | 9 (75.0) | |
| Preoperative aneurysm size, n (%) | 50.8 ± 8.0 | 50.9 ± 11.9 | 0.970 b |
| . | No PGS . | PGS (+) . | P-value . |
|---|---|---|---|
| . | Data (N = 70) . | Data (N = 12) . | . |
| Male, n (%) | 42 (60.0) | 7 (58.3) | >0.999 a |
| Female, n (%) | 28 (40.0) | 5 (41.7) | |
| Age, n (%) | 74.6 ± 8.9 | 71.4 ± 12.2 | 0.287 b |
| Body surface area (m2) | 1.6 ± 0.2 | 1.6 ± 0.2 | 0.721 b |
| Hyperlipidaemia, n (%) | 38 (55.1) | 7 (58.3) | >0.999 a |
| Anticoagulation (W/D), n (%) | 17 (24.3) | 4 (33.3) | 0.493 a |
| Warfarin, n (%) | 10 (14.3) | 4 (33.3) | 0.205 a |
| Aspirin, n (%) | 27 (37.5) | 4 (40) | >0.999 a |
| Steroid, n (%) | 3 (4.2) | 1 (10) | 0.412 a |
| Diuretics, n (%) | 26 (36.1) | 3 (30) | >0.999 a |
| Diabetes mellitus, n (%) | 14 (20.0) | 2 (16.7) | >0.999 a |
| Smoking, n (%) | 24 (34.3) | 6 (50.0) | 0.341 a |
| Hypertension, n (%) | 56 (80.0) | 12 (100.0) | 0.116 a |
| Peripheral vascular disease, n (%) | 13 (18.6) | 2 (16.7) | >0.999 a |
| Lung disease, n (%) | 6 (8.6) | 1 (8.3) | >0.999 a |
| Arrhythmia, n (%) | 4 (5.7) | 0 (0.0) | >0.999 a |
| Previous angina, MI, n (%) | 8 (11.4) | 1 (8.3) | >0.999 a |
| Cerebral vascular disease, n (%) | 14 (20.0) | 2 (16.7) | >0.999 a |
| Previous heart surgery, n (%) | 9 (12.9) | 1 (9.1) | >0.999 a |
| Preoperative albumin level, n (%) | 4.1 ± 0.3 | 4.1 ± 0.4 | 0.888 b |
| Haemodialysis, n (%) | 4 (5.7) | 1 (8.3) | 0.556 a |
| Serum creatinine (mg/dl) | 0.9 [0.6, 1.2] | 0.9 [0.8, 1.3] | 0.455 c |
| Ejection fraction (%) | 62.8 ± 7.1 | 67.4 ± 4.1 | 0.032 b |
| Aortic valve, n (%) | 0.716 a | ||
| Aortic stenosis (AS) | 4 (5.7) | 1 (8.3) | |
| Aortic regurgitation (AR) | 14 (20.0) | 3 (25.0) | |
| AS + AR/ASR | 8 (11.4) | 2 (16.7) | |
| Mitral valve, n (%) | 7 (10.0) | 3 (25.0) | 0.159 a |
| Degenerative aneurysm, n (%) | 42 (60.0) | 3 (25.0) | 0.031 a |
| Aortic dissection (type A/B), n (%) | 28 (40.0) | 9 (75.0) | |
| Preoperative aneurysm size, n (%) | 50.8 ± 8.0 | 50.9 ± 11.9 | 0.970 b |
P-value: (a) unpaired t-test; (b) Fisher's exact test; and (c) Mann–Whitney U test. Values are presented as number (%) or mean (SD) or median [IQR].
ASR: aortic stenosis and regurgitation; IQR: interquartile range; anticoagulation (W/D): warfarin or direct oral anticoagulant; aortic dissection (type A/B): DeBakey type A or B; SD: standard deviation.
Bold represents the statistical significance.
Baseline characteristics: non-perigraft seroma patients versus perigraft seroma patients
| . | No PGS . | PGS (+) . | P-value . |
|---|---|---|---|
| . | Data (N = 70) . | Data (N = 12) . | . |
| Male, n (%) | 42 (60.0) | 7 (58.3) | >0.999 a |
| Female, n (%) | 28 (40.0) | 5 (41.7) | |
| Age, n (%) | 74.6 ± 8.9 | 71.4 ± 12.2 | 0.287 b |
| Body surface area (m2) | 1.6 ± 0.2 | 1.6 ± 0.2 | 0.721 b |
| Hyperlipidaemia, n (%) | 38 (55.1) | 7 (58.3) | >0.999 a |
| Anticoagulation (W/D), n (%) | 17 (24.3) | 4 (33.3) | 0.493 a |
| Warfarin, n (%) | 10 (14.3) | 4 (33.3) | 0.205 a |
| Aspirin, n (%) | 27 (37.5) | 4 (40) | >0.999 a |
| Steroid, n (%) | 3 (4.2) | 1 (10) | 0.412 a |
| Diuretics, n (%) | 26 (36.1) | 3 (30) | >0.999 a |
| Diabetes mellitus, n (%) | 14 (20.0) | 2 (16.7) | >0.999 a |
| Smoking, n (%) | 24 (34.3) | 6 (50.0) | 0.341 a |
| Hypertension, n (%) | 56 (80.0) | 12 (100.0) | 0.116 a |
| Peripheral vascular disease, n (%) | 13 (18.6) | 2 (16.7) | >0.999 a |
| Lung disease, n (%) | 6 (8.6) | 1 (8.3) | >0.999 a |
| Arrhythmia, n (%) | 4 (5.7) | 0 (0.0) | >0.999 a |
| Previous angina, MI, n (%) | 8 (11.4) | 1 (8.3) | >0.999 a |
| Cerebral vascular disease, n (%) | 14 (20.0) | 2 (16.7) | >0.999 a |
| Previous heart surgery, n (%) | 9 (12.9) | 1 (9.1) | >0.999 a |
| Preoperative albumin level, n (%) | 4.1 ± 0.3 | 4.1 ± 0.4 | 0.888 b |
| Haemodialysis, n (%) | 4 (5.7) | 1 (8.3) | 0.556 a |
| Serum creatinine (mg/dl) | 0.9 [0.6, 1.2] | 0.9 [0.8, 1.3] | 0.455 c |
| Ejection fraction (%) | 62.8 ± 7.1 | 67.4 ± 4.1 | 0.032 b |
| Aortic valve, n (%) | 0.716 a | ||
| Aortic stenosis (AS) | 4 (5.7) | 1 (8.3) | |
| Aortic regurgitation (AR) | 14 (20.0) | 3 (25.0) | |
| AS + AR/ASR | 8 (11.4) | 2 (16.7) | |
| Mitral valve, n (%) | 7 (10.0) | 3 (25.0) | 0.159 a |
| Degenerative aneurysm, n (%) | 42 (60.0) | 3 (25.0) | 0.031 a |
| Aortic dissection (type A/B), n (%) | 28 (40.0) | 9 (75.0) | |
| Preoperative aneurysm size, n (%) | 50.8 ± 8.0 | 50.9 ± 11.9 | 0.970 b |
| . | No PGS . | PGS (+) . | P-value . |
|---|---|---|---|
| . | Data (N = 70) . | Data (N = 12) . | . |
| Male, n (%) | 42 (60.0) | 7 (58.3) | >0.999 a |
| Female, n (%) | 28 (40.0) | 5 (41.7) | |
| Age, n (%) | 74.6 ± 8.9 | 71.4 ± 12.2 | 0.287 b |
| Body surface area (m2) | 1.6 ± 0.2 | 1.6 ± 0.2 | 0.721 b |
| Hyperlipidaemia, n (%) | 38 (55.1) | 7 (58.3) | >0.999 a |
| Anticoagulation (W/D), n (%) | 17 (24.3) | 4 (33.3) | 0.493 a |
| Warfarin, n (%) | 10 (14.3) | 4 (33.3) | 0.205 a |
| Aspirin, n (%) | 27 (37.5) | 4 (40) | >0.999 a |
| Steroid, n (%) | 3 (4.2) | 1 (10) | 0.412 a |
| Diuretics, n (%) | 26 (36.1) | 3 (30) | >0.999 a |
| Diabetes mellitus, n (%) | 14 (20.0) | 2 (16.7) | >0.999 a |
| Smoking, n (%) | 24 (34.3) | 6 (50.0) | 0.341 a |
| Hypertension, n (%) | 56 (80.0) | 12 (100.0) | 0.116 a |
| Peripheral vascular disease, n (%) | 13 (18.6) | 2 (16.7) | >0.999 a |
| Lung disease, n (%) | 6 (8.6) | 1 (8.3) | >0.999 a |
| Arrhythmia, n (%) | 4 (5.7) | 0 (0.0) | >0.999 a |
| Previous angina, MI, n (%) | 8 (11.4) | 1 (8.3) | >0.999 a |
| Cerebral vascular disease, n (%) | 14 (20.0) | 2 (16.7) | >0.999 a |
| Previous heart surgery, n (%) | 9 (12.9) | 1 (9.1) | >0.999 a |
| Preoperative albumin level, n (%) | 4.1 ± 0.3 | 4.1 ± 0.4 | 0.888 b |
| Haemodialysis, n (%) | 4 (5.7) | 1 (8.3) | 0.556 a |
| Serum creatinine (mg/dl) | 0.9 [0.6, 1.2] | 0.9 [0.8, 1.3] | 0.455 c |
| Ejection fraction (%) | 62.8 ± 7.1 | 67.4 ± 4.1 | 0.032 b |
| Aortic valve, n (%) | 0.716 a | ||
| Aortic stenosis (AS) | 4 (5.7) | 1 (8.3) | |
| Aortic regurgitation (AR) | 14 (20.0) | 3 (25.0) | |
| AS + AR/ASR | 8 (11.4) | 2 (16.7) | |
| Mitral valve, n (%) | 7 (10.0) | 3 (25.0) | 0.159 a |
| Degenerative aneurysm, n (%) | 42 (60.0) | 3 (25.0) | 0.031 a |
| Aortic dissection (type A/B), n (%) | 28 (40.0) | 9 (75.0) | |
| Preoperative aneurysm size, n (%) | 50.8 ± 8.0 | 50.9 ± 11.9 | 0.970 b |
P-value: (a) unpaired t-test; (b) Fisher's exact test; and (c) Mann–Whitney U test. Values are presented as number (%) or mean (SD) or median [IQR].
ASR: aortic stenosis and regurgitation; IQR: interquartile range; anticoagulation (W/D): warfarin or direct oral anticoagulant; aortic dissection (type A/B): DeBakey type A or B; SD: standard deviation.
Bold represents the statistical significance.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
